57 Neoadjuvant doxorubicin/cyclophosphamide followed by weekly paclitaxel for operable or locally advanced breast cancer: outcome analysis of 72 patients treated at a single institution

M.Tokar; M.Koretz; T.Hertz; O.Bloshitski; B.Delgado; N.Sion-Vardy; S.Ariad; M.Bayme; D.B.Geffen

首页> 外文期刊>European Journal of Cancer Supplements >57 Neoadjuvant doxorubicin/cyclophosphamide followed by weekly paclitaxel for operable or locally advanced breast cancer: outcome analysis of 72 patients treated at a single institution

【24h】

57 Neoadjuvant doxorubicin/cyclophosphamide followed by weekly paclitaxel for operable or locally advanced breast cancer: outcome analysis of 72 patients treated at a single institution

机译：57新辅助药阿霉素/环磷酰胺，然后每周一次紫杉醇治疗可手术或局部晚期乳腺癌：单机构治疗72例患者的结局分析

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2010年第3期|共1页
作者
M.Tokar; M.Koretz; T.Hertz; O.Bloshitski; B.Delgado; N.Sion-Vardy; S.Ariad; M.Bayme; D.B.Geffen;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
入库时间 2022-08-18 18:38:40

相似文献

外文文献
中文文献
专利

1. 57 Neoadjuvant doxorubicin/cyclophosphamide followed by weekly paclitaxel for operable or locally advanced breast cancer: outcome analysis of 72 patients treated at a single institution [J] . M.Tokar, M.Koretz, T.Hertz, European Journal of Cancer Supplements . 2010,第3期

机译：57新辅助药阿霉素/环磷酰胺，然后每周一次紫杉醇治疗可手术或局部晚期乳腺癌：单机构治疗72例患者的结局分析
2. Neoadjuvant chemotherapy with low dose of pegylated liposomal doxorubicin plus weekly paclitaxel in operable and locally advanced breast cancer. [J] . Rossi D, Baldelli AM, Casadei V, Anti-cancer drugs . 2008,第7期

机译：在可手术和局部晚期乳腺癌中，低剂量聚乙二醇化阿霉素加每周一次紫杉醇的新辅助化疗。
3. Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9 [J] . Abraham Jame, Robidoux Andr, Tan Antoinette R., Breast cancer research and treatment. . 2015,第2期

机译：NSABP基金会研究FB-9，评估II期随机临床试验，评估每周辅助用紫杉醇或艾瑞布林联合阿霉素和环磷酰胺的新辅助化疗方案对局部晚期HER2阴性乳腺癌妇女的作用
4. Characterizing tumor changes during neoadjuvant treatment of locally advanced breast cancer patients (LABC) using dynamicenhanced magnetic resonance imaging (DE-MRI) [C] . Oana I. Craciunescu, Ellen L. Jones, Kimberly L. Blackwell, Society of Photo-Optical Instrumentation Engineers (SPIE);SPIE Proceedings . 2005

机译：使用动态增强磁共振成像（DE-MRI）表征局部晚期乳腺癌患者（LABC）新辅助治疗期间的肿瘤变化
5. Diffusion-weighted magnetic resonance imaging in monitoring treatment response in patients with locally advanced breast cancer. [D] . Singer, Lisa. 2010

机译：扩散加权磁共振成像可监测局部晚期乳腺癌患者的治疗反应。
6. Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally advanced breast cancer: analysis of 126 patients [O] . A A Ezzat, E M Ibrahim, D S Ajarim, 2004

机译：新辅助紫杉醇和顺铂治疗可手术和局部晚期乳腺癌的II期研究：126例患者的分析
7. A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer [O] . Lynn Symonds, Isaac Jenkins, Hannah M Linden, 2021

机译：A II期研究评估Sunitinib苹果酸的安全性和功效与每周紫杉醇组合，然后是多柔比星和每日口服环磷酰胺加G-CSF作为局部晚期或炎症乳腺癌的Neoadjuvant化疗

57 Neoadjuvant doxorubicin/cyclophosphamide followed by weekly paclitaxel for operable or locally advanced breast cancer: outcome analysis of 72 patients treated at a single institution

著录项

相似文献

相关主题

期刊订阅